EyePoint Pharmaceuticals Inc. buy Chardan Capital
Start price
03.08.23
/
50%
€11.30
Target price
03.08.24
€20.11
Performance (%)
-27.96%
Price
12.07.24
€9.48
This prediction will end soon
Summary
This prediction is currently active. The price of EyePoint Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.96%. This prediction currently runs until 03.08.24. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
EyePoint Pharmaceuticals Inc. | - | - |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Chardan_Capital for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $22.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Chardan_Capital for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.25
28.06.24
28.06.24
€26.15
28.06.25
28.06.25
14.88%
12.07.24
12.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.92
07.05.24
07.05.24
€25.98
07.05.25
07.05.25
-4.42%
12.07.24
12.07.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.92
03.03.23
03.03.23
€19.79
03.03.24
03.03.24
797.26%
04.03.24
04.03.24